{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:22:06Z","timestamp":1791332526707,"version":"4.3.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.diabet.2009.01.001","type":"journal-article","created":{"date-parts":[[2009,2,27]],"date-time":"2009-02-27T09:28:52Z","timestamp":1235726932000},"page":"151-154","source":"Crossref","is-referenced-by-count":19,"title":["Long-term improvement of metabolic control with pioglitazone in a woman with diabetes mellitus related to Dunnigan syndrome: A case report"],"prefix":"10.1016","volume":"35","author":[{"given":"C.","family":"Collet-Gaudillat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Billon-Bancel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-P.","family":"Beressi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2009.01.001_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1006\/mgme.2000.3092","article-title":"Familial partial lipodystrophy: a monogenic form of the insulin resistance syndrome","volume":"71","author":"Hegele","year":"2000","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.diabet.2009.01.001_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S1262-3636(07)70227-6","article-title":"Etiological investigations in apparent type 2 diabetes: when to search for lamin A\/C mutations?","volume":"31","author":"Donadille","year":"2005","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2009.01.001_bib3","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2337\/diabetes.54.6.1873","article-title":"Type A insulin resistance syndrome revealing a novel lamin A mutation","volume":"54","author":"Young","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2009.01.001_bib4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1464-5491.2003.01034.x","article-title":"Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene","volume":"20","author":"Owen","year":"2003","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2009.01.001_bib5","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1210\/jc.2003-031658","article-title":"Patients with familial partial lipodystrophy of the Dunnigan Type due to LMNA R482W mutation show muscular and cardiac abnormalities","volume":"89","author":"Vantyghem","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2009.01.001_bib6","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1464-5491.2005.01757.x","article-title":"Long-term treatment experience in a subject with Dunnigan type familial partial lipodystrophy: efficacy of rosiglitazone","volume":"22","author":"Ludtke","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2009.01.001_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.diabet.2007.04.005","article-title":"Efficacy of pioglitazone in familial partial lipodystrophy of the Dunnigan type: a case report","volume":"33","author":"Moreau","year":"2007","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2009.01.001_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4158\/EP.13.6.656","article-title":"Efficacy and safety of pioglitazone in treatment of a patient with an atypical partial lipodystrophy syndrome","volume":"13","author":"Sleilati","year":"2007","journal-title":"Endocr Pract"},{"key":"10.1016\/j.diabet.2009.01.001_bib9","first-page":"2007","article-title":"A pathogenic mechanism leading to partial lipodistrophy and prospects for pharmacological treatment of insulin resistance syndrome","volume":"78","author":"Maraldi","year":"2007","journal-title":"Acta Biomed"},{"key":"10.1016\/j.diabet.2009.01.001_bib10","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.metabol.2006.11.010","article-title":"Long-term efficacy of leptin replacement in patients with Dunnigan-type familial partial lipodystrophy","volume":"56","author":"Park","year":"2007","journal-title":"Metabolism"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S126236360900010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S126236360900010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,21]],"date-time":"2018-12-21T10:25:38Z","timestamp":1545387938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S126236360900010X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S126236360900010X"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2009.01.001","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}